CD16/PD-L1 BI-SPECIFIC APTAMER FOR CANCER IMMUNOTHERAPY THROUGH RECRUITING NK CELLS AND ACTING AS IMMUNOCHECKPOINT BLOCKADE

CD16/PD-L1 bi-specific aptamer for cancer immunotherapy through recruiting NK cells and acting as immunocheckpoint blockade

It is well established that natural killer (NK) cells can be used as an alternative candidate of T cells for adoptive cell therapy (ACT) due to its high killing capacity, off-the-shelf utility, and low toxicity.Though NK cells provide rapid and potent immune effects, they still suffer from insufficient infiltration and tumor immunosuppression envir

read more




The Optical Properties of Leaf Structural Elements and Their Contribution to Photosynthetic Performance and Photoprotection

Leaves have evolved to effectively harvest light, and, in parallel, to balance photosynthetic CO2 assimilation with water losses.At times, leaves must operate under light limiting conditions while at other instances (temporally distant or even within seconds), the same leaves must modulate light capture to avoid photoinhibition and achieve a unifor

read more